Back

FBXW7β isoform drives transcriptional activation of a proinflammatory TNF cluster in normal and malignant pro-B cells

Yang, S. Y.; Hayer, K. E.; Fazelinia, H.; Asnani, M.; Black, K. L.; Naqvi, A. S.; Pillai, V.; Spruce, L. A.; Barash, Y.; Elenitoba-Johnson, K. S.; Thomas-Tikhonenko, A.

2022-04-25 cell biology
10.1101/2022.04.24.489313 bioRxiv
Show abstract

Non-canonical exon usage plays many important roles in cellular phenotypes, but its contribution to human B-cell development remains sketchily understood. To fill this gap, we collected various B-cell fractions from bone marrow and tonsil donors, performed RNA-seq, and examined transcript variants. We identified 150 genes that harbor local splicing variations in all pairwise comparisons. One of them encodes FBXW7, an E3 ubiquitin ligase implicated as a cancer driver in several blood cancers. Surprisingly, we discovered that in normal human pro-B cells, the predominant transcript utilized an alternative first exon to produce the poorly characterized FBXW7{beta} isoform, previously thought to be restricted to neural tissues. The FBXW7{beta} transcript was also abundant in cell lines and primary samples of pediatric B-cell acute lymphoblastic leukemia (B-ALL), which originates in the bone marrow. When overexpressed in a heterologous cell system, this transcript yielded the expected protein product, as judged by anti-FLAG immunoblotting and mass spectrometry. Furthermore, in REH B-ALL cells, FBXW7{beta} mRNA was the only FBXW7 isoform enriched in the polyribosome fraction. To shed light on possible functions of FBXW7{beta}, we utilized gain- and loss-of-function approaches and identified an FBXW7{beta}-dependent inflammatory gene signature, apparent in a subset of B-ALL with high FBXW7{beta} expression. This signature contained several members of the TNF superfamily, including those comprising the HLA Class III cluster (LTB, LST1, NCR3, LTA, and NFKBIL1). Our findings suggest that FBXW7{beta} expression drives proinflammatory responses, which could contribute to normal B-cell development, leukemogenesis and responses to anti-cancer therapies. Key pointsO_LIPreviously thought to be restricted to neural tissues, FBXW7{beta} is the predominant FBXW7 isoform in normal and malignant human pro-B cells. C_LIO_LIFBXW7{beta} promotes transcriptional activation of a proinflammatory gene cluster that contains TNF superfamily members. C_LI

Matching journals

The top 3 journals account for 50% of the predicted probability mass.

1
Blood
67 papers in training set
Top 0.1%
23.1%
2
Blood Advances
54 papers in training set
Top 0.1%
14.7%
3
Haematologica
24 papers in training set
Top 0.1%
12.8%
50% of probability mass above
4
eLife
5422 papers in training set
Top 29%
3.1%
5
iScience
1063 papers in training set
Top 7%
2.8%
6
Leukemia
39 papers in training set
Top 0.4%
2.1%
7
British Journal of Haematology
15 papers in training set
Top 0.2%
1.8%
8
Nature Communications
4913 papers in training set
Top 50%
1.7%
9
Cell Reports
1338 papers in training set
Top 23%
1.7%
10
PLOS ONE
4510 papers in training set
Top 53%
1.7%
11
JCI Insight
241 papers in training set
Top 3%
1.7%
12
Scientific Reports
3102 papers in training set
Top 61%
1.5%
13
PLOS Genetics
756 papers in training set
Top 10%
1.5%
14
Frontiers in Genetics
197 papers in training set
Top 6%
1.4%
15
Life Science Alliance
263 papers in training set
Top 0.5%
1.4%
16
Journal of Experimental Medicine
106 papers in training set
Top 3%
0.9%
17
Proceedings of the National Academy of Sciences
2130 papers in training set
Top 42%
0.8%
18
Journal of Leukocyte Biology
40 papers in training set
Top 0.4%
0.8%
19
International Journal of Molecular Sciences
453 papers in training set
Top 15%
0.8%
20
EMBO reports
136 papers in training set
Top 6%
0.8%
21
Oncogene
76 papers in training set
Top 2%
0.7%
22
The Journal of Immunology
146 papers in training set
Top 2%
0.7%
23
Oncogenesis
12 papers in training set
Top 0.2%
0.7%
24
Molecular Cancer
14 papers in training set
Top 1%
0.7%
25
EMBO Molecular Medicine
85 papers in training set
Top 5%
0.7%
26
Genome Medicine
154 papers in training set
Top 9%
0.7%
27
Nucleic Acids Research
1128 papers in training set
Top 19%
0.7%
28
Clinical and Translational Medicine
30 papers in training set
Top 1%
0.7%
29
Cell Death & Disease
126 papers in training set
Top 3%
0.7%
30
Frontiers in Immunology
586 papers in training set
Top 10%
0.5%